The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 359:2392-2393 November 27, 2008 Number 22
NextNext

Nodal Dissection for Gastric Cancer

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Sasako, M.
-PubMed Citation
To the Editor: The article by Sasako et al. (July 31 issue)1 addresses the efficacy of D2 lymphadenectomy alone versus D2 lymphadenectomy plus para-aortic nodal dissection (PAND) for gastric cancer. The finding of nearly equivalent rates of survival among patients undergoing D2 lymphadenectomy alone (69.2%) and those also undergoing PAND (70.3%) seems to indicate that lymphadenectomy for gastric cancer may be more of a staging exercise than a treatment. This result lends credence to the strategies of neoadjuvant chemotherapy and adjuvant chemoradiotherapy2,3,4 that have been shown to improve survival among patients with gastric cancer, a disease that has generally been . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.